Trusted Capital Marketplace. I'll bet ya that eMagin is one of the 50 or so companies in the hopper that have trouble reaching, connecting with, finding an interested partner for a capital infusion. We need a softened process. We've pulled this wagon, heavy laden a long time. I'm going to guess eMagin is 6 layers down.

MS. LORD:  Yeah.

We continue to look at the fragility of the defense-industrial base, especially around some of the components four, five, six layers down in the chain.  And we talk with industry about where there are issues and problems.

We're using some of the authorities Congress has given us:  DPA Title III, IBAS, (inaudible).

MS. LORD:  So Defense Production Act, Title III.  IBAS, we will get you what that acronym is.  I'm violating my own rule here.

(Laughter.)

But basically, these are authorities that allow us to put money into the industrial base to stand up capabilities for which there's not a clear, robust business model right now to keep the capability there for our defense purposes.

But what we've been doing is working with the implementation of the 13806 Defense Industrial Base E.O. report.  And we are getting presidential determinations that allow us to spend money against certain areas.  So we can get you a list of all the presidential determinations.  That's one way we fund it to get things going.

But we do continue to talk to the Hill about where we have concerns.  And a large focus of our industrial policy team is to make sure we do work in those areas where we need a softened processing of some of those items versus actually getting them initially.

And again, these are things that might come into the Trusted Capital Marketplace where we need capital infusion to stand up capability.